Risk-adapted modulation through deintensification of cancer treatments: an ESMO classification.

Hannoun-Levi, J-M; Gutierrez, C; Polgar, C; Strnad, V

Hannoun-Levi, J-M; Gutierrez, C; Polgar, C; Strnad, V.

Afiliación

Hannoun-Levi JM; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University Côte d'Azur, Nice, France. Electronic address: jean-michel.hannoun-levi@nice.unicancer.fr.
Gutierrez C; Department of Radiation Oncology, Catalan Institute of Oncology, Barcelona, Spain.
Polgar C; Center of Radiotherapy, National Institute of Oncology, Budapest, Hungary; Department of Oncology, Semmelweis University, Budapest, Hungary.
Strnad V; Department of Radiation Oncology, Erlangen University Hospital, Erlangen, Germany.

Ann Oncol ; 33(10): 1088, 2022 10.

Article en En | MEDLINE | ID: mdl-35803547

Asunto(s)

Neoplasias; Humanos; Neoplasias/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google